Anti-Obesity Drugs (China)
Contents
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II.BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS
Anti-Obesity Drugs Industry Structure
Market Size
Market Growth Drivers
Anti-Obesity Drugs Industry Capacity
Major Producer Facility Locations and Output
Locations
Output
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development
IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND
Overview
Demand of Anti-Obesity Drugs by Region
Anti-Obesity Drugs Production and Demand
Sibutramine
Major Manufacturers
Supply and Demand
Traditional Chinese Medicine
Major Manufacturers
Supply and Demand
Orlistat
Major Manufacturers
Supply and Demand
Rimonabant
Major Manufacturers
Supply and Demand
Metformin
Major Manufacturers
Supply and Demand
Other Anti-Obesity Drugs
Anti-Obesity Drugs Imports and Exports
Anti-Obesity Drugs Imports
Anti-Obesity r Drugs Exports
Pricing Trend
V. ANTI-OBESITY DRUGS MARKET OUTLOOK
Anti-Obesity Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits
VI. MARKETING STRATEGIES
China Market Entry Overview
China’s Distribution System
Cough Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China’s Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise
VII. ANTI-OBESITY DRUGS PRODUCER DIRECTORY
Profiles of Anti-Obesity Drugs Producers and Major Suppliers
LIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
III. ANTI-OBESITY TREATMENT DRUGS INDUSTRY ASSESSMENTS
Anti-Obesity Drugs Industry Output
Major Producer Facility Location
Major Anti-Obesity Drugs Producer Output in 2007
Market Share of Key Producers
Major Foreign Investment in China
IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND
Anti-Obesity Drugs Production and Demand
Demand of Anti-Obesity Drugs by Region in 2004
Major Sibutramine Producer Output and Capacity in 2007
Sibutramine Drugs Production and Demand
Major Traditional Chinese medicine Producer Output and Capacity in 2007 Traditional Chinese Medicine Production and Demand
Major Orlistat Producer Output and Capacity in 2007
Olistat Production and Demand
Rimonabant Production and Demand
Major Metformin Producer Output and Capacity in 2007
Metformin Production and Demand
Other Anti-obesity Drugs Production and Demand
China Anti-Obesity Drugs Imports and Exports
V. ANTI-OBESITY DRUGS MARKET OUTLOOK
Anti-Obesity Drugs Industry Output
Major Producer Facility Location
Major Anti-Obesity Drugs Producer Output in 2007
Market Share of Key Producers in 2007
Major Foreign Investment in China
LIST OF CHARTS
I. INTRODUCTION
China’s Anti-Obesity Drugs Capacity, Output, Demand
II. BUSINESS ENVIRONMENT
China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports
III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS
Anti-Obesity Drugs Capacity in China
All kinds of Anti-Obesity Drugs Market Share
Anti-Obesity Drugs Capacity, Output and Demand
IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND
Total Anti-Obesity Drugs Production and Demand
Total Anti-Obesity Drugs Imports and Exports
V. ANTI-OBESITY DRUGS MARKET OUTLOOK
Anti-Obesity Drugs Demand by Market in 2009
VI. MARKETING STRATEGIES
China’s Distribution Channel